Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00762216 · ClinicalTrials.gov registry record · NA

Rotational Stability of the AcrySof® Toric

A NA study of Cataract, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
71
Enrollment target
1
Study location

NCT00762216: Completed NA study of Cataract, sponsored by Alcon Research.

NCT00762216 is a NA study of Cataract that has completed, run by Alcon Research. The registered enrollment target is 71 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00762216, a NA study of Cataract, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target
1
Study location

Study Summary

To assess the rotational stability and the residual refractive cylinder and patient reported outcomes of the AcrySof Toric intraocular lens after unilateral or bilateral implantation.

Primary Outcome

Average magnitude of intraocular lens (IOL) rotation from day of surgery to 6-months post-surgery, measured in degrees.

Conditions Studied

Interventions

  • DEVICE AcrySof® Toric intraocular lens

Study Locations (1)

Texas

  • Alcon Call Center - Fort Worth

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2008-05
Phase NA
Alcon Research

275 total trials

What the finished NCT00762216 record still lists

NCT00762216 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (69% lower).

The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which AcrySof® Toric intraocular lens is the first listed.

NCT00762216 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00762216 about?

NCT00762216 is a clinical study titled "Rotational Stability of the AcrySof® Toric". To assess the rotational stability and the residual refractive cylinder and patient reported outcomes of the AcrySof Toric intraocular lens after unilateral or bilateral implantation.

What is the current status of trial NCT00762216?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2008-05.

What conditions does trial NCT00762216 study?

This clinical trial studies the following conditions: Cataract.

What interventions are being tested in trial NCT00762216?

The interventions under investigation include: AcrySof® Toric intraocular lens (DEVICE).

Who is sponsoring clinical trial NCT00762216?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00762216 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00762216's enrollment target sits among peer trials

71 47th of 83 higher than 37 of 83 other Cataract trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05452889 · 71 participants · Early Phase 1

    PET Image in PAH Patients

  • NCT05766943 · 71 participants · NA

    Reduction of Myopotential Interference With Smart Pass in S-ICD Patients

  • NCT06229678 · 71 participants · Early Phase 1

    Ketones, SGLT2, HFrEF

  • NCT06377566 · 71 participants · Phase 2

    A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00762216, the US trial registry maintained by the National Library of Medicine. NCT00762216 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.